L26/O-226 Developmental competence of vitrified–warmed enucleated oocytes supports the feasibility of using a bank of cryopreserved cytoplasts for maternal spindle transfer in a mouse model
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N. Costa-Borges und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can enucleated mouse oocytes (cytoplasts) be vitrified, stored, and successfully used for maternal spindle transfer (MST) without compromising developmental competence? Summary answer Vitrified–warmed enucleated oocytes show high survival and spindle transfer efficiency, with embryo development comparable to controls, supporting cytoplast bank feasibility for MST use. What is known already Maternal spindle transfer is a promising mitochondrial replacement therapy aimed at preventing the transmission of mitochondrial diseases or treating extreme female infertility cases associated with fertilization failure or massive embryo developmental arrest. However, the procedure is technically demanding and requires precise synchronization between donor and patient oocytes. Establishing a bank of cytoplasts to be used on a needs-based could simplify the procedure, reduce the time required to perform the technique and improve oocyte utilization. Despite these potential advantages, the developmental competence and post-warming functionality of vitrified cytoplasts and their feasibility for use in MST remains unknown. Study design, size, duration This proof-of-concept study in mice included 729 oocytes. Oocytes were collected, enucleated, vitrified, stored in liquid nitrogen, and warmed for MST. Non-manipulated oocytes served as controls or spindle donors either fresh or after 24 h of in vitro aging (IVA) as a model of poor oocyte quality. Post-warming survival, MST efficiency, and embryonic developmental outcomes were compared across groups using vitrified or fresh cytoplasts reconstructed with fresh or IVA spindles, and their corresponding controls. Participants/materials, setting, methods MII-oocytes were collected from superovulated (B6CBAF1) female mice. Cytoplasts were generated by enucleation and vitrified using a short-exposure ES/VS protocol and an open cryo device. After warming, vitrified and fresh cytoplasts were reconstructed with meiotic spindles taken from either fresh or IVA oocytes. Karyoplast-cytoplast fusion was achieved using inactivated Sendai virus. All reconstructed oocytes were inseminated by piezo-ICSI,cultured to the blastocyst stage, vitrified and transferred to synchronized pseudo-pregnant females to assess in-vivo development to term. Main results and the role of chance Cytoplast survival after vitrification-warming was 98.8% (n = 395/400). Enucleation and reconstruction efficiencies were above 90% in all MST groups. The control group using fresh oocytes (n = 242) exhibited 96.3% survival after ICSI and 72.7% blastocyst formation while the in vitro-aged control (n = 92) showed 92.4% post-ICSI survival, with complete developmental arrest and no blastocyst development. The MST group using fresh spindles that were transferred to vitrified–warmed cytoplasts (n = 93) achieved a 96.0% survival to ICSI and 61.1% blastocyst formation. MST using spindles from in vitro-aged oocytes with fresh cytoplasts (n = 132) resulted in 88.1% ICSI survival and 61.3% blastocyst development. MST using in vitro-aged spindles with vitrified cytoplasts (n = 170) yielded 96% ICSI survival and 55.9% blastocyst formation. Embryo transfers resulted in live birth rates of 52.5% for fresh controls (n = 40), 34.1% for MST with in vitro-aged spindles and fresh cytoplasts (n = 41), and 36.7% for MST with in vitro-aged spindles and vitrified cytoplasts (n = 30), with no statistically significant differences between groups (p > 0.05; Chi-square). All pups were healthy and developed normally until adulthood. Limitations, reasons for caution This study was conducted in a mouse model. While results demonstrate that cytoplasts can be successfully vitrified, warmed and reconstructed, retaining developmental competence, further studies are needed to confirm that human oocytes behave similarly. Such confirmation is essential before considering clinical translation for MST using a bank of vitrified cytoplasts. Wider implications of the findings These results demonstrate the feasibility of establishing a bank of vitrified cytoplasts for MST, significantly simplifying the procedure, enabling faster execution, improving synchronization with patients’ spindle-donor oocytes, enhancing oocyte utilization, and reducing the logistical constraints associated with relying on fresh donor oocytes. Trial registration number No
Zitieren
APA
Costa-Borges, N., Acacio, M., Savash, M., Matia-Algué, Q., Mestres, E., & Wells, D. (2026). L26/O-226 Developmental competence of vitrified–warmed enucleated oocytes supports the feasibility of using a bank of cryopreserved cytoplasts for maternal spindle transfer in a mouse model. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.224
Vancouver
Costa-Borges N, Acacio M, Savash M, Matia-Algué Q, Mestres E, Wells D. L26/O-226 Developmental competence of vitrified–warmed enucleated oocytes supports the feasibility of using a bank of cryopreserved cytoplasts for maternal spindle transfer in a mouse model. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.224
BibTeX
@article{CostaBorges2026,
author = {Costa-Borges, N. and Acacio, M. and Savash, M. and Matia-Algué, Q. and Mestres, E. and Wells, D.},
title = {L26/O-226 Developmental competence of vitrified–warmed enucleated oocytes supports the feasibility of using a bank of cryopreserved cytoplasts for maternal spindle transfer in a mouse model},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.224}
}
EUVIMED